Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 164.60% | 155.60% | 162.47% | 30.54% | 8.31% |
| Total Depreciation and Amortization | -21.41% | -25.05% | -19.71% | -14.26% | -7.93% |
| Total Amortization of Deferred Charges | -16.16% | -68.08% | -57.22% | -45.71% | -25.00% |
| Total Other Non-Cash Items | -1,167.82% | -1,339.10% | -442.35% | 152.54% | 204.51% |
| Change in Net Operating Assets | 161.01% | 78.90% | 58.10% | -177.13% | -126.04% |
| Cash from Operations | 63.34% | 58.25% | 50.46% | 42.10% | -71.26% |
| Capital Expenditure | -- | -- | -- | 97.26% | -275.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 0.00% |
| Cash from Investing | -29.58% | -64.70% | -64.87% | -100.01% | -0.44% |
| Total Debt Issued | -- | -- | -- | -100.00% | -180.96% |
| Total Debt Repaid | -248.57% | -- | -- | -- | 162.63% |
| Issuance of Common Stock | 5,776.10% | 511.57% | -- | -99.27% | -96.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | 4,790.87% | 234.79% | -103.28% | -101.31% | -98.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 220.10% | 70.55% | -162.66% | -183.73% | -158.99% |